FDA Panel Advises Patient Consent With Power Morcellators To Warn Of Cancer Risk
This article was originally published in The Gray Sheet
Executive Summary
FDA’s Obstetrics and Gynecology Devices Advisory panel recommended a mandatory patient consent form, signed by both patient and physician, for use of laparascopic power morcellators during minimally invasive hysterectomy, and advised the morcellators not be used in individuals with suspected malignant sarcomas.